STATE STREET CORP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 183 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2024. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2024$37,105,455
-43.9%
1,523,838
-22.3%
0.00%
-33.3%
Q1 2024$66,187,039
+28.8%
1,959,936
+20.3%
0.00%
+50.0%
Q4 2023$51,383,369
+20.6%
1,629,666
-2.3%
0.00%0.0%
Q3 2023$42,615,484
-25.1%
1,667,925
-15.9%
0.00%
-33.3%
Q2 2023$56,905,938
+6.1%
1,984,168
-11.3%
0.00%0.0%
Q1 2023$53,644,836
-30.0%
2,237,999
-50.4%
0.00%
+50.0%
Q4 2022$76,586,136
+89.3%
4,515,692
+65.4%
0.00%
-33.3%
Q3 2022$40,465,000
-8.4%
2,730,462
-2.7%
0.00%0.0%
Q2 2022$44,181,000
-49.1%
2,806,918
-12.8%
0.00%
-25.0%
Q1 2022$86,756,000
+14.0%
3,217,957
+56.5%
0.00%0.0%
Q4 2021$76,095,000
+8.3%
2,056,074
+39.8%
0.00%0.0%
Q3 2021$70,253,000
+18.2%
1,470,341
-16.3%
0.00%
+33.3%
Q2 2021$59,411,000
+2.9%
1,755,654
+25.6%
0.00%0.0%
Q1 2021$57,739,000
+31.5%
1,398,035
+38.2%
0.00%0.0%
Q4 2020$43,897,000
-34.4%
1,011,919
-35.1%
0.00%
-40.0%
Q3 2020$66,935,000
+455.0%
1,560,254
+504.7%
0.01%
+400.0%
Q2 2020$12,060,000258,0220.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2024
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 204,673$10,164,0006.19%
CVI Holdings, LLC 200,032$9,349,0003.47%
DAFNA Capital Management LLC 149,017$6,965,0002.01%
Cormorant Asset Management, LP 800,000$37,392,0001.43%
ARK Investment Management 1,918,835$89,686,0000.96%
EAM Global Investors LLC 30,948$1,447,0000.65%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,362,0000.61%
Monashee Investment Management LLC 79,497$3,716,0000.56%
EAM Investors, LLC 40,695$1,902,0000.42%
Diametric Capital, LP 11,478$536,0000.41%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders